Alfred Halstensen

Emeritus

Department of Clinical Science

E-mailalfred.halstensen@uib.no
Visitor Address
Haukeland universitetssykehus, Laboratoriebygget

5009 Bergen
Postal Address
Postboks 7804

5020 Bergen

Publications

Academic article

Show author(s) (2023). Dietary fish intake increased the concentration of soluble ACE2 in rats. Can fish consumption reduce the risk of COVID-19 infection through interception of SARS-CoV-2 by soluble ACE2? British Journal of Nutrition. 1-8.

Show author(s) (2022). Intake of residuals from Atlantic cod attenuated blood pressure increase but did not delay development of kidney damage in obese Zucker fa/fa rats. Food & Nutrition Research (FNR). 1-11.

Show author(s) (2020). Effect of cod residual protein supplementation on markers of glucose regulation in lean adults: A randomized double-blind study. Nutrients. 1-12.

Show author(s) (2019). Cod protein powder lowered serum nonesterified fatty acids and increased total bile acid concentrations in healthy, lean, physically active adults: A randomized double-blind study. Food & Nutrition Research (FNR). 9 pages.

Show author(s) (2018). Daily intake of protein from cod residual material lowers serum concentrations of nonesterified fatty acids in overweight healthy adults: A randomized double-blind pilot study. Marine Drugs. 1-15.
Show author(s) (2018). Cod Residual Protein Prevented Blood Pressure Increase in Zucker fa/fa Rats, Possibly by Inhibiting Activities of Angiotensin-Converting Enzyme and Renin. Nutrients. 1820.

Show author(s) (2017). High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA content in the leucocyte membrane in healthy overweight adults: A randomised trial. British Journal of Nutrition. 1368-1378.

Show author(s) (2013). Meningococcal Omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in mice. Scandinavian Journal of Immunology. 452-459.

Show author(s) (2011). Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenza-specific CD4+Th1-cell responses. Influenza and Other Respiratory Viruses. 376-379.
Show author(s) (2011). Pandemic Influenza Vaccination Elicits Influenza-Specific CD4(+) Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. Scandinavian Journal of Immunology. 210-218.

Show author(s) (2006). Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002. Epidemiology and Infection. 103-110.
Show author(s) (2006). High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002. Epidemiology and Infection. 1195-1202.

Show author(s) (2003). FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiology and Infection. 193-199.

Show author(s) (2001). Infeksjoner med gruppe A-streptokokker i hud, bløtdeler og blod. Tidsskrift for Den norske legeforening. 3310-3314.

Show author(s) (2000). Phagocytosis: measurement by flow cytometry. JIM - Journal of Immunological Methods. 229-242.
Show author(s) (2000). Phagocytosis: measurement by flow cytometry. JIM - Journal of Immunological Methods. 229-242.
Show author(s) (2000). Patterns of cell death induced by eluates of denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
Show author(s) (2000). Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
Show author(s) (2000). Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
Show author(s) (2000). Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. Journal of Antimicrobial Chemotherapy. 457-459.
Show author(s) (2000). Concurrent measurement of antigen- and antibody dependent oxidative burst and phagocytosis in monocytes and neutrophils. Meth Enzymol. 203-220.
Show author(s) (2000). Concurrent measurement of antigen- and antibody dependent oxidative burst and phagocytosis in monocytes and neutrophils. Methods Enzymol. 203-220.

Show author(s) (1999). Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiology and Infection. 373-382.
Show author(s) (1999). Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infection and Immunity. 2552-2560.
Show author(s) (1999). Human opsonins induced during mengococcal disease recognize transferrin binding protein complexes. Infection and Immunity. 6526-6532.
Show author(s) (1999). Human opsonins induced during mengococcal disease recognise outer membrane proteins PorA and PorB. Infection and Immunity. 2552-2560.
Show author(s) (1999). Functional differentiation of acute myeloid leukaemia blast cells. APMIS - Journal of Pathologiy, Microbiology and Immunology. 1023-1033.

Show author(s) (1998). Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. Cytometry. 406-413.
Show author(s) (1998). Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immynogenisity og a group B Neisseria meningitidis outer mebrane vesicle vaccine. Developments in Biologicals. 323-333.
Show author(s) (1998). Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Developments in Biologicals. 323-333.
Show author(s) (1998). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Developments in Biologicals. 323-333.

Show author(s) (1997). Interleukin 4 responses in acute leukemia patients with severe chemotherapy-induced leucopenia. European Journal of Haematology. 269-276.
Show author(s) (1997). Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. European Journal of Haematology. 269-276.
Show author(s) (1997). Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. JIM - Journal of Immunological Methods. 55-68.

Show author(s) (1996). The role of cytokines in the pathogenesis of Neisseria meningitidis infection. Current Opinion in Infectious Diseases. 146-149.
Show author(s) (1996). Serum Levels of Adhesion Molecules and Cytokines in Patients with Acute Leukaemia. Leukemia and Lymphoma. 423-450.
Show author(s) (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with imipenem or cefuroxime/metronidazole. Immunology & Infectious Diseases. 159-166.
Show author(s) (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with Imipenem or Cefuroxime/Metronidazole. Immunology & Infectious Diseases. 159-166.
Show author(s) (1996). Endotoxin and cytokines in plasma and clinical evaluation during treatment of septicemia with imipenem or cefuroxim/metronidazol. Immunology & Infectious Diseases.

Show author(s) (1995). Strain differentiation of Neisseria meningitidis by small-fragment restriction endonuclease analysis (SF-REA). APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.
Show author(s) (1995). Strain differentiation of Neisseria meningitidis by small fragment res triction endonuclease analysis. APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.
Show author(s) (1995). Small-fragment restriction endonuclease analysis of Neisseria meningitidis carrier strains. APMIS - Journal of Pathologiy, Microbiology and Immunology.
Show author(s) (1995). Single dose oflozacin to eradicate pharyngeal carriage of Neisseria me ningitidis. Drugs. 399-400.
Show author(s) (1995). Single dose ofloxacin to eradicate pharyngeal carriage of Neisseria meningitidis. Drugs. 399-400.
Show author(s) (1995). High levels of Interleukin 10 in serum are associated with fatality in meningococcal disease. Infection and Immunity. 2109-2112.
Show author(s) (1995). Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis. Drugs. 454-456.
Show author(s) (1995). Double blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis. Drugs. 454-456.
Show author(s) (1995). Clonal diversity of Neisseria meningitidis carrier strains. APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.

Show author(s) (1994). Sequele one year after meningococcal disease. Acta Neurologica Scandinavica. 139-142.
Show author(s) (1994). Sequelae one year after meningococcal disease. Acta Neurologica Scandinavica. 139-162.
Show author(s) (1994). Sequelae one year after meningococcal disease. Acta Neurologica Scandinavica. 139-142.
Show author(s) (1994). Necrotizing fasciitis due to group A streptococci in western Norway: Incidence and clinical features. The Lancet. 1111-1115.
Show author(s) (1994). Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. The Lancet. 1111-1115.
Show author(s) (1994). Necrotising fasciitis due to group A streptococci in Western Norway: incidence and clinical features. The Lancet. 1111-1115.
Show author(s) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
Show author(s) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
Show author(s) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
Show author(s) (1994). Cytokines in meningococcal disease. Baillière's Clinical Infectious Diseases. 97-108.

Show author(s) (1993). Use of single-dose ofloxacin to eradicate tonsillo-pharyngeal carriage of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy. 2024-2026.
Show author(s) (1993). Single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy. 2024-2026.
Show author(s) (1993). Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. Journal of Infectious Diseases. 471-475.
Show author(s) (1993). Crossreacting serum opsonins to meningococci after vaccination. Journal of Infectious Diseases. 1314-1319.
Show author(s) (1993). Cross-reacting serum opsonins to meningococci after vaccination. Journal of Infectious Diseases. 1314-1319.
Show author(s) (1993). Compartmentalization of the TNF and IL-6 in meningitis and septic shock. Mediators of Inflammation. 23-25.

Show author(s) (1992). Spectrum of disease in bacteremic patients during a streptococcus pyogenes serotype M-1 epidemic in Norway 1988. European Journal of Clinical Microbiology and Infectious Diseases. 416-425.
Show author(s) (1992). Monocyte phagocytosis of opsonized neisseria meningtides serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
Show author(s) (1992). Monocyte phagocytosis of opsonized Neisseria meningitidis serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
Show author(s) (1992). Monocyte phagocytosis of opsonized Neisseria meningitidis serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
Show author(s) (1992). Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microbial Pathogenesis. 423-431.
Show author(s) (1992). Epidemilogical studies of antimeningococcal IgM and IgG serum antibodies by an enzyme linked immunosorbent assay (ELISA) using whole bacterium as antigen. Scandinavian Journal of Infectious Diseases. 47-55.
Show author(s) (1992). Crossreacting serum opsonins in patients with meningococcal disease. Infection and Immunity. 2777-2783.
Show author(s) (1992). Cross-reacting serum opsonins in patients with meningococcal disease. Infection and Immunity. 2777-2783.

Show author(s) (1991). Serum opsonins to serogroup B meningococci after vaccination. NIPH Annals. 107-167.
Show author(s) (1991). Opsonin response in vaccinees as measured by chemiluminesence. APMIS - Journal of Pathologiy, Microbiology and Immunology. 769-772.
Show author(s) (1991). Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence. APMIS - Journal of Pathologiy, Microbiology and Immunology. 769-772.
Show author(s) (1991). Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. The Lancet. 1093-1096.
Show author(s) (1991). Diagnosis of systemic meningococcal disease. NIPH Annals. 107-123.
Show author(s) (1991). Current understanding of the pathogenesis of gram negative shock. Infectious Disease Clinics of North America. 781-791.

Report

Show author(s) (1993). Alvorlige streptokokk gruppe A bakterimier vinteren 1992-93. .

Popular scientific lecture

Show author(s) (1996). Ny metode for utvelgelse av opsonininduserende meningokokkantigener.
Show author(s) (1996). Gamle bakterier i endret drakt.

Show author(s) (1994). Uspesifikt forsvar mot mikroorganismer.
Show author(s) (1994). Strategi og behandling av sepsis.
Show author(s) (1994). Septikemi hos den immunkompetente og hos den gravt nautropene pasient.
Show author(s) (1994). Pneumokokkvaksinen.
Show author(s) (1994). Nekrotiserende fasciitt.
Show author(s) (1994). Meningokokkvaksinen.
Show author(s) (1994). Meningokokksykdommen - farligst klokken ni om morgenen?
Show author(s) (1994). Meningokokkseptikemi. Nekrotiserende fasciitt.
Show author(s) (1994). Kvinoloner og cefalosporiner.
Show author(s) (1994). Introduksjon.
Show author(s) (1994). Infeksjonsprofylakse ved utenlandsreiser.
Show author(s) (1994). Infeksjonsmedisinske kasuistikker.
Show author(s) (1994). Infeksiøse tarmlidelser.
Show author(s) (1994). Immunterapeutiske muligheter ved septikemi.
Show author(s) (1994). Hudmanifestasjoner ved infeksjonssykdommer.
Show author(s) (1994). Herpes zoster og komplikasjoner.
Show author(s) (1994). Herpes zoster - klinikk, komplikasjoner og behandling (foredrag + gruppearbeid).
Show author(s) (1994). Gruppe A streptokokker: Mikrobiologi, epidemiologi og kliniske manifestasjoner.
Show author(s) (1994). Alvorlige infeksjoner på Vestlandet.
Show author(s) (1994). Alvorlige infeksjoner med gruppe A streptokokker.
Show author(s) (1994). Alvorlige infeksjoner med gruppe A streptokokker.
Show author(s) (1994). Alvorlige infeksjoner - diagnostikk og behandling før sykehusinnleggelse.
Show author(s) (1994). Akutt bakteriell enteritt.

Academic lecture

Show author(s) (2002). Praktisk antibiotikabruk.
Show author(s) (2002). Mennesket og mikroben.
Show author(s) (2002). Meningokokksepsis.
Show author(s) (2002). Menigokokksykdom.
Show author(s) (2002). Hvordan bruker vi pressen?
Show author(s) (2002). Hudmanifestasjoner ved infeksjonssykdommer.
Show author(s) (2002). Gastroenteritt.
Show author(s) (2002). Cross-reacting and cross-protective antibodies against Neisseria meningitidis and Neisseria lactamica in human postvaccination and patient sera.
Show author(s) (2002). CNS-infeksjoner.
Show author(s) (2002). Alvorlige streptokokkinfeksjoner.

Show author(s) (2001). Øvre urinveisinfeksjoner. Urosepsis.
Show author(s) (2001). The clinical picture of meningococcal disease.
Show author(s) (2001). Stafylokokk- og streptokokkinfeksjoner.
Show author(s) (2001). Reducing meningitis mortality by different information - data driven action.
Show author(s) (2001). Praktisk antbiotikabruk.
Show author(s) (2001). Opsonophagocytosis of meningococci.
Show author(s) (2001). Mennesket og mikroben.
Show author(s) (2001). Meningokokksykdommer.
Show author(s) (2001). Meningokokksepsis.
Show author(s) (2001). Meningokokk-vaksinen.
Show author(s) (2001). Meningitt og hjerneabscess.
Show author(s) (2001). Makrolider.
Show author(s) (2001). Infeksjoner i luftveiene.
Show author(s) (2001). Infeksjoner i hud/bløtdeler.
Show author(s) (2001). Hudmanifestasjoner ved infeksjonssykdommer.
Show author(s) (2001). Gastroenteritter.
Show author(s) (2001). Bakterielle tarminfeksjoner. Etiologi, patogenese.
Show author(s) (2001). Antibiotikabruk og økonomi.
Show author(s) (2001). Alvorlige streptokokkinfeksjoner.

Show author(s) (2000). Meningokokkvaksine ved reiser.
Show author(s) (2000). Meningokokkvaksine ved reiser.

Show author(s) (1998). Patient opsonins against specific meningococcal outer membrane components.
Show author(s) (1998). Meningococcal disease outbreak due to a new strain C:15:P1.7,16 in Western Norway, and selective carriage eradication of this strain.

Show author(s) (1997). Media og smittestoffer.

Show author(s) (1996). Opsonophagocytosis responses to meningococcal antigens adsorbed to beads.
Show author(s) (1996). High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.
Show author(s) (1996). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.

Show author(s) (1995). Clinical aspects of serious invasive group A streptococcal disease.

Show author(s) (1994). Single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis (poster).
Show author(s) (1994). Single-dose ofloxacin to eradicate pharyngeal carriage of Neisseria meningitidis (poster).
Show author(s) (1994). Increased incedence of necrotizing fasciitis caused by group A streptococci in Western Norway.
Show author(s) (1994). Double blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis (poster).
Show author(s) (1994). Alvorlige gruppe A-streptokokkinfeksjoner i Norge 1993-1994.

Reader opinion piece

Show author(s) (2001). Kommunikasjon, kvalitet og omstilling. På Høyden ( UiBs nettavis).

Non-fiction book

Show author(s) (1994). Terapianbefalinger: Akutte luftveisinfeksjoner i primærhelsetjenesten. Statens legemiddelkontroll, Oslo.